I agree that this site is using cookies. You can find further informations here.
X
Aslan, Burcu
302  results:
Search for persons X
?
1

Transcriptomic and proteomic differences in BTK-WT and BTK-..:

Aslan, Burcu ; Manyam, Ganiraju ; Iles, LaKesla R...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
2

Correction: MicroRNA 603 acts as a tumor suppressor and inh..:

Bayraktar, Recep ; Pichler, Martin ; Kanlikilicer, Pinar...
Oncotarget.  14 (2023)  1 - p. 908-909 , 2023
Link: https://doi.org/10.18632..
 
?
3

Curing CLL: one clone at a time:

Aslan, Burcu ; Tantawy, Shady I. ; Gandhi, Varsha
Blood Advances.  7 (2023)  9 - p. 1926-1928 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Corrigendum to "PTGER3 induces ovary tumorigenesis and conf..:

Rodriguez-Aguayo, Cristian ; Bayraktar, Emine ; Ivan, Cristina...
eBioMedicine.  83 (2022)  - p. 104194 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Poster: CLL-532 Changes in Proteome of CLL (Chronic Lymphoc..:

Timofeeva, Natalia ; Jain, Nitin ; Irajizad, Ehsan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S144 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosi..:

Aslan, Burcu ; Kismali, Gorkem ; Iles, Lakesla R....
Blood Cancer Journal.  12 (2022)  5 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
7

CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leu..:

Timofeeva, Natalia ; Jain, Nitin ; Irajizad, Ehsan...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S283 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Development and characterization of prototypes for in vitro..:

Aslan, Burcu ; Kismali, Gorkem ; Chen, Lisa S....
Blood Advances.  5 (2021)  16 - p. 3134-3146 , 2021
Link: https://doi.org/10.1182/..
 
?
9

Vecabrutinib inhibits B-cell receptor signal transduction i..:

Aslan, Burcu ; Hubner, Stefan Edward ; Fox, Judith A....
Haematologica.  107 (2021)  1 - p. 292-297 , 2021
Link: https://doi.org/10.3324/..
 
?
10

ncRNA therapy with miRNA-22-3p suppresses the growth of tri..:

Gorur, Aysegul ; Bayraktar, Recep ; Ivan, Cristina...
Molecular Therapy - Nucleic Acids.  23 (2021)  - p. 930-943 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Corrigendum to 'Exosomal miRNA confers chemo resistance via..:

Kanlikilicer, Pinar ; Bayraktar, Recep ; Denizli, Merve...
EBioMedicine.  52 (2020)  - p. 102630 , 2020
Link: https://doi.org/10.1016/..
 
?
12

PTGER3 induces ovary tumorigenesis and confers resistance t..:

Rodriguez-Aguayo, Cristian ; Bayraktar, Emine ; Ivan, Cristina...
EBioMedicine.  40 (2019)  - p. 290-304 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Monitoring the effects of land sizes on private property tr..:

Ince, Cankut D. ; Aslan, Burcu
Sustainable Cities and Society.  50 (2019)  - p. 101632 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Exosomal miRNA confers chemo resistance via targeting Cav1/..:

Kanlikilicer, Pinar ; Bayraktar, Recep ; Denizli, Merve...
eBioMedicine.  38 (2018)  - p. 100-112 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Exosomal miR-940 maintains SRC-mediated oncogenic activity ..:

Rashed, Mohammed H. ; Kanlikilicer, Pinar ; Rodriguez-Aguayo, Cristian...
Oncotarget.  8 (2017)  12 - p. 20145-20164 , 2017
Link: https://doi.org/10.18632..
 
1-15